{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:37:30Z","timestamp":1784389050753,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"European Social Fund under the Global Grant measure","award":["Grant VP1-3.1-SMM-07-K-02-060"],"award-info":[{"award-number":["Grant VP1-3.1-SMM-07-K-02-060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0226-2","type":"journal-article","created":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T15:05:20Z","timestamp":1455807920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study"],"prefix":"10.1186","volume":"16","author":[{"given":"Julija","family":"Brozaitiene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narseta","family":"Mickuviene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelija","family":"Podlipskyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3928-2151","authenticated-orcid":false,"given":"Julius","family":"Burkauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robertas","family":"Bunevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,18]]},"reference":[{"issue":"7","key":"226_CR1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","volume":"344","author":"I Klein","year":"2001","unstructured":"Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501\u20139.","journal-title":"N Engl J Med"},{"issue":"8","key":"226_CR2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/clc.20171","volume":"30","author":"WH Yin","year":"2007","unstructured":"Yin WH, Chen JW, Feng AN, Lin SJ, Young S. Multimarker approach to risk stratification among patients with advanced chronic heart failure. Clin Cardiol. 2007;30(8):397\u2013402.","journal-title":"Clin Cardiol"},{"issue":"1","key":"226_CR3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2010.06.053","volume":"57","author":"P Damman","year":"2011","unstructured":"Damman P, Beijk MA, Kuijt WJ, Verouden NJ, van Geloven N, Henriques JP, et al. Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2011;57(1):29\u201336.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"226_CR4","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"I Klein","year":"2007","unstructured":"Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725\u201335.","journal-title":"Circulation"},{"issue":"7","key":"226_CR5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1515\/CCLM.2001.093","volume":"39","author":"J Mair","year":"2001","unstructured":"Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med. 2001;39(7):571\u201388.","journal-title":"Clin Chem Lab Med"},{"issue":"14","key":"226_CR6","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","volume":"345","author":"JA Lemos de","year":"2001","unstructured":"de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345(14):1014\u201321.","journal-title":"N Engl J Med"},{"issue":"3","key":"226_CR7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejim.2006.11.007","volume":"18","author":"R Pfister","year":"2007","unstructured":"Pfister R, Tan D, Thekkanal J, Hellmich M, Schneider CA. NT-pro-BNP is associated with long-term outcome in a heterogeneous sample of cardiac inpatients. Eur J Intern Med. 2007;18(3):215\u201320.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"226_CR8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijcard.2006.04.038","volume":"115","author":"M Grabowski","year":"2007","unstructured":"Grabowski M, Filipiak KJ, Malek LA, Karpinski G, Huczek Z, Stolarz P, et al. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Int J Cardiol. 2007;115(3):386\u201390.","journal-title":"Int J Cardiol"},{"issue":"1\u20132","key":"226_CR9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cca.2006.02.010","volume":"370","author":"A Gegenhuber","year":"2006","unstructured":"Gegenhuber A, Mueller T, Dieplinger B, Poelz W, Pacher R, Haltmayer M. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure. Clin Chim Acta. 2006;370(1\u20132):174\u20139.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"226_CR10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0009-8981(01)00578-2","volume":"310","author":"A Hammerer-Lercher","year":"2001","unstructured":"Hammerer-Lercher A, Neubauer E, Muller S, Pachinger O, Puschendorf B, Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta. 2001;310(2):193\u20137.","journal-title":"Clin Chim Acta"},{"issue":"7","key":"226_CR11","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0735-1097(01)01672-2","volume":"38","author":"J Koglin","year":"2001","unstructured":"Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, von Scheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol. 2001;38(7):1934\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"226_CR12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-12-0627","volume":"167","author":"B Biondi","year":"2012","unstructured":"Biondi B. Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur J Endocrinol. 2012;167(5):609\u201318.","journal-title":"Eur J Endocrinol"},{"issue":"14","key":"226_CR13","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/archinte.167.14.1526","volume":"167","author":"G Iervasi","year":"2007","unstructured":"Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, Mariani F, et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med. 2007;167(14):1526\u201332.","journal-title":"Arch Intern Med"},{"issue":"6","key":"226_CR14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/105072502760143908","volume":"12","author":"DD Ascheim","year":"2002","unstructured":"Ascheim DD, Hryniewicz K. Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. Thyroid. 2002;12(6):511\u20135.","journal-title":"Thyroid"},{"issue":"21","key":"226_CR15","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.2169\/internalmedicine.51.7902","volume":"51","author":"B Zhang","year":"2012","unstructured":"Zhang B, Peng W, Wang C, Li W, Xu Y. A low fT3 level as a prognostic marker in patients with acute myocardial infarctions. Internal Med (Tokyo, Japan). 2012;51(21):3009\u201315.","journal-title":"Internal Med (Tokyo, Japan)"},{"issue":"2","key":"226_CR16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/eje.0.1430179","volume":"143","author":"T Kimura","year":"2000","unstructured":"Kimura T, Kanda T, Kotajima N, Kuwabara A, Fukumura Y, Kobayashi I. Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction. Eur J Endocrinol. 2000;143(2):179\u201384.","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"226_CR17","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/archinte.162.12.1388","volume":"162","author":"L Friberg","year":"2002","unstructured":"Friberg L, Werner S, Eggertsen G, Ahnve S. Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? Arch Intern Med. 2002;162(12):1388\u201394.","journal-title":"Arch Intern Med"},{"issue":"2","key":"226_CR18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.amjmed.2004.07.052","volume":"118","author":"A Pingitore","year":"2005","unstructured":"Pingitore A, Landi P, Taddei MC, Ripoli A, L\u2019Abbate A, Iervasi G. Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med. 2005;118(2):132\u20136.","journal-title":"Am J Med"},{"issue":"2","key":"226_CR19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1054\/jcaf.2001.24665","volume":"7","author":"H Shanoudy","year":"2001","unstructured":"Shanoudy H, Soliman A, Moe S, Hadian D, Veldhuis JD, Iranmanesh A, et al. Early manifestations of \u201csick euthyroid\u201d syndrome in patients with compensated chronic heart failure. J Card Fail. 2001;7(2):146\u201352.","journal-title":"J Card Fail"},{"issue":"1","key":"226_CR20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cardfail.2008.08.008","volume":"15","author":"C Passino","year":"2009","unstructured":"Passino C, Pingitore A, Landi P, Fontana M, Zyw L, Clerico A, et al. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure. J Card Fail. 2009;15(1):35\u201340.","journal-title":"J Card Fail"},{"issue":"2","key":"226_CR21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5603\/CJ.2013.0027","volume":"20","author":"J Nessler","year":"2013","unstructured":"Nessler J, Nessler B, Golebiowska-Wiatrak R, Palka I, Gackowski A, Kitlinski M, et al. Serum biomarkers and clinical outcomes in heart failure patients treated de novo with carvedilol. Cardiol J. 2013;20(2):144\u201351.","journal-title":"Cardiol J"},{"issue":"19","key":"226_CR22","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/01.CIR.0000097109.90783.FC","volume":"108","author":"M Cesari","year":"2003","unstructured":"Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003;108(19):2317\u201322.","journal-title":"Circulation"},{"issue":"5","key":"226_CR23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0002-9149(97)00434-7","volume":"80","author":"G Pannitteri","year":"1997","unstructured":"Pannitteri G, Marino B, Campa PP, Martucci R, Testa U, Peschle C. Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction. Am J Cardiol. 1997;80(5):622\u20135.","journal-title":"Am J Cardiol"},{"issue":"7","key":"226_CR24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/hc3201.094973","volume":"104","author":"DA Smith","year":"2001","unstructured":"Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation. 2001;104(7):746\u20139.","journal-title":"Circulation"},{"issue":"12","key":"226_CR25","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.RES.0000130526.20854.fa","volume":"94","author":"M Nian","year":"2004","unstructured":"Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94(12):1543\u201353.","journal-title":"Circ Res"},{"issue":"6","key":"226_CR26","first-page":"1695","volume":"77","author":"A Boelen","year":"1993","unstructured":"Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM. Association between serum interleukin-6 and serum 3,5,3\u2032-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab. 1993;77(6):1695\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"226_CR27","first-page":"1342","volume":"79","author":"JM Stouthard","year":"1994","unstructured":"Stouthard JM, van der Poll T, Endert E, Bakker PJ, Veenhof CH, Sauerwein HP, et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab. 1994;79(5):1342\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"226_CR28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/eje.0.1380603","volume":"138","author":"L Bartalena","year":"1998","unstructured":"Bartalena L, Bogazzi F, Brogioni S, Grasso L, Martino E. Role of cytokines in the pathogenesis of the euthyroid sick syndrome. Eur J Endocrinol. 1998;138(6):603\u201314.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"226_CR29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.biopha.2009.09.001","volume":"64","author":"V Lubrano","year":"2010","unstructured":"Lubrano V, Pingitore A, Carpi A, Iervasi G. Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure. Biomed Pharmacother. 2010;64(3):165\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"226_CR30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/vhrm.2006.2.3.221","volume":"2","author":"R Osman","year":"2006","unstructured":"Osman R, L\u2019Allier PL, Elgharib N, Tardif JC. Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vasc Health Risk Manag. 2006;2(3):221\u201337.","journal-title":"Vasc Health Risk Manag"},{"issue":"20","key":"226_CR31","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"PG Steg","year":"2012","unstructured":"Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569\u2013619.","journal-title":"Eur Heart J"},{"issue":"1","key":"226_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HJR.0b013e3283313592","volume":"17","author":"MF Piepoli","year":"2010","unstructured":"Piepoli MF, Corra U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010;17(1):1\u201317.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"38","key":"226_CR33","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"G Montalescot","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949\u20133003.","journal-title":"Eur Heart J"},{"issue":"2","key":"226_CR34","first-page":"66","volume":"16","author":"J Burkauskas","year":"2014","unstructured":"Burkauskas J, Mickuviene N, Brozaitiene J, Staniute M, Podlipskyte A, Rastenyte D, et al. Gene-environment interactions connecting Low triiodothyronine syndrome and outcomes of cardiovascular disease (GET-VASC): study protocol. Biological Psychiatry and Psychopharmacology. 2014;16(2):66\u201373.","journal-title":"Biological Psychiatry and Psychopharmacology"},{"key":"226_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-014-0204-2","volume":"13","author":"M Staniute","year":"2015","unstructured":"Staniute M, Brozaitiene J, Burkauskas J, Kazukauskiene N, Mickuviene N, Bunevicius R. Type D personality, mental distress, social support and health-related quality of life in coronary artery disease patients with heart failure: a longitudinal observational study. Health Qual Life Outcomes. 2015;13:1.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"226_CR36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"issue":"2","key":"226_CR37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2009.03.137","volume":"144","author":"R Pfister","year":"2010","unstructured":"Pfister R, Strack N, Wielckens K, Malchau G, Erdmann E, Schneider CA. The relationship and prognostic impact of low-T3 syndrome and NT-pro-BNP in cardiovascular patients. Int J Cardiol. 2010;144(2):187\u201390.","journal-title":"Int J Cardiol"},{"issue":"4","key":"226_CR38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.33549\/physiolres.931172","volume":"57","author":"O Mayer Jr","year":"2008","unstructured":"Mayer Jr O, Simon J, Cech J, Rosolova H, Hrbkova J, Pikner R, et al. Even mild changes in free thyroxine could influence the degree of heart failure measured by its biological surrogates. Physiol Res. 2008;57(4):525\u20139.","journal-title":"Physiol Res"},{"issue":"5","key":"226_CR39","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/01.CIR.0000048124.64204.3F","volume":"107","author":"G Iervasi","year":"2003","unstructured":"Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003;107(5):708\u201313.","journal-title":"Circulation"},{"issue":"9","key":"226_CR40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0002-9343(01)00980-9","volume":"111","author":"L Friberg","year":"2001","unstructured":"Friberg L, Drvota V, Bjelak AH, Eggertsen G, Ahnve S. Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction. Am J Med. 2001;111(9):699\u2013703.","journal-title":"Am J Med"},{"issue":"5","key":"226_CR41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.amjcard.2013.11.039","volume":"113","author":"CP Chuang","year":"2014","unstructured":"Chuang CP, Jong YS, Wu CY, Lo HM. Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure. Am J Cardiol. 2014;113(5):845\u201350.","journal-title":"Am J Cardiol"},{"issue":"2","key":"226_CR42","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.amjcard.2012.02.068","volume":"110","author":"S Selvaraj","year":"2012","unstructured":"Selvaraj S, Klein I, Danzi S, Akhter N, Bonow RO, Shah SJ. Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction. Am J Cardiol. 2012;110(2):234\u20139.","journal-title":"Am J Cardiol"},{"issue":"12","key":"226_CR43","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/oxfordjournals.eurheartj.a014804","volume":"17","author":"C Opasich","year":"1996","unstructured":"Opasich C, Pacini F, Ambrosino N, Riccardi PG, Febo O, Ferrari R, et al. Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J. 1996;17(12):1860\u20136.","journal-title":"Eur Heart J"},{"issue":"7","key":"226_CR44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/clc.20574","volume":"32","author":"M Coceani","year":"2009","unstructured":"Coceani M, Iervasi G, Pingitore A, Carpeggiani C, L\u2019Abbate A. Thyroid hormone and coronary artery disease: from clinical correlations to prognostic implications. Clin Cardiol. 2009;32(7):380\u20135.","journal-title":"Clin Cardiol"},{"issue":"1","key":"226_CR45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejheart.2004.04.016","volume":"7","author":"G Kozdag","year":"2005","unstructured":"Kozdag G, Ural D, Vural A, Agacdiken A, Kahraman G, Sahin T, et al. Relation between free triiodothyronine\/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy. Eur J Heart Fail. 2005;7(1):113\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"226_CR46","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1210\/jc.2005-0535","volume":"90","author":"RP Peeters","year":"2005","unstructured":"Peeters RP, Wouters PJ, van Toor H, Kaptein E, Visser TJ, Van den Berghe G. Serum 3,3\u2032,5\u2032-triiodothyronine (rT3) and 3,5,3\u2032-triiodothyronine\/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab. 2005;90(8):4559\u201365.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"226_CR47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cardfail.2006.05.009","volume":"12","author":"A Pingitore","year":"2006","unstructured":"Pingitore A, Iervasi G, Barison A, Prontera C, Pratali L, Emdin M, et al. Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction. J Card Fail. 2006;12(7):520\u20136.","journal-title":"J Card Fail"},{"key":"226_CR48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2261-14-67","volume":"14","author":"X Li","year":"2014","unstructured":"Li X, Chen C, Gan F, Wang Y, Ding L, Hua W. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study. BMC Cardiovasc Disord. 2014;14:67.","journal-title":"BMC Cardiovasc Disord"},{"key":"226_CR49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2261-13-69","volume":"13","author":"AL Hawkes","year":"2013","unstructured":"Hawkes AL, Patrao TA, Ware R, Atherton JJ, Taylor CB, Oldenburg BF. Predictors of physical and mental health-related quality of life outcomes among myocardial infarction patients. BMC Cardiovasc Disord. 2013;13:69.","journal-title":"BMC Cardiovasc Disord"},{"key":"226_CR50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2261-11-57","volume":"11","author":"R Leon de la Fuente","year":"2011","unstructured":"Leon de la Fuente R, Naesgaard PA, Nilsen ST, Woie L, Aarsland T, Gallo P, et al. B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina. BMC Cardiovasc Disord. 2011;11:57.","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"226_CR51","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1507\/endocrj.K08E-010","volume":"55","author":"CH Jung","year":"2008","unstructured":"Jung CH, Rhee EJ, Shin HS, Jo SK, Won JC, Park CY, et al. Higher serum free thyroxine levels are associated with coronary artery disease. Endocr J. 2008;55(5):819\u201326.","journal-title":"Endocr J"},{"issue":"9","key":"226_CR52","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.amjcard.2015.07.070","volume":"116","author":"JR Popelova","year":"2015","unstructured":"Popelova JR, Kotaska K, Tomkova M, Tomek J. Usefulness of N-terminal Pro-brain natriuretic peptide to predict mortality in adults with congenital heart disease. Am J Cardiol. 2015;116(9):1425\u201330.","journal-title":"Am J Cardiol"},{"issue":"2\u20134","key":"226_CR53","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.3909\/ricm0644","volume":"14","author":"G Wei","year":"2013","unstructured":"Wei G, Yaqi R, Ningfu W, Xuwei H. N-terminal prohormone B-type natriuretic peptide and cardiovascular risk in stable coronary artery disease: a meta-analysis of nine prospective studies. Rev Cardiovasc Med. 2013;14(2\u20134):e92\u20138.","journal-title":"Rev Cardiovasc Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0226-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T13:10:14Z","timestamp":1654348214000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2261\/16\/45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,18]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["226"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0226-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,18]]},"article-number":"45"}}